SignalChem’s New 2019-nCoV RBD-N Protein Chimera

Expedite your Covid-19 research with SignalChem’s new 2019-nCoV Spike RBD-N Protein Chimera.

SignalChem’s new 2019-nCoV Spike RBD-N Protein Chimera is an important research and detection tool to study the novel SARS-CoV-2 and its molecular interactions with the host cell. Our high-quality RBD-N Chimera can be used for the detection and quantification of SARS-CoV-2 spike protein S1 (RBD) and Nucleocapsid (N) Protein from recombinant or biological samples.

  • Stronger binding affinity than that of individual S & N proteins.
  • Only one test required to capture both anti-S and anti-N antibodies.
  • Suitable for R&D of SARS-CoV-2 antibody detection tests.

View the 2019-nCoV Spike RBD-N Protein Chimera here.